Tagged With Biotech

We're on the brink of the first new treatment for Alzheimer's in almost two decades. Here's what you need to know.


An investment firm raked in $730 million in a single day after making a huge bet on a biotech stock


Could treatments for Alzheimer's disease and concussions be hanging out unused in your medicine cabinet? This think tank thinks so — and wants to put them to work.



Dispensed: A digital health IPO bust, Walmart's push into healthcare, and an MIT project that didn't live up to the hype


We got an inside look at how the biotech Spark used mazes to develop a first-of-its-kind treatment for eye disease on the way to selling itself for $4.8 billion


We got a look at the pitch deck of buzzy Silicon Valley health-tech startup Sempre Health. It reveals how a $4 billion industry is ripe for disruption.



Dispensed: Career advice from BI's young healthcare leaders, a wild week for biotechs, and a list of white-hot AI startups


Dispensed: A big week for digital health IPOs, what happens when a $2.1 million drug can't get to the kids who need it, and what a top health-tech VC is looking to invest in


Biogen climbs as profits surge 72%, prompting the firm to boost 2019 guidance


Belgian biotech Galapagos surges after Gilead sinks another $5.1 billion into the firm


Dispensed: Pharma's next big megamerger, a string of healthcare IPOs, and why the CEO of Clover Health regrets setting up shop in Silicon Valley


Forget Beyond Meat — Adaptive Biotechnologies just spiked 95% in its public trading debut, marking the year’s best post-IPO pop



Dispensed: Young blood startup is back, a scoop about CityMD, and telling remarks from Merck's CEO


Array BioPharma spikes more than 50% after Pfizer shells out $11 billion for the cancer-drug developer


Dispensed: The inside story of uBiome, a visit to the largest health system in New York, and what it's like to take a 'biotech for dummies' course


We took the two-day, $1,300 'biotech for dummies' class where healthcare executives, HR managers, and investors catch up on science for the first time since high school



Why everybody gets duped by hot health and science startups


Dispensed: A record-breaking approval, what it's like to work in healthcare, and a call for nominations


The inside story of how the Silicon Valley burger startup Impossible Foods is going global after its sizzling Burger King debut


Digital health startups worth $7.6 billion are set to IPO, breaking a 3-year drought. Here's what 5 top VCs are keeping an eye on.